FETOMATERNAL OUTCOME IN OBESE PREGNANT WOMEN WITH PREGNANCY INDUCED HYPERTENSION VISITING LIAQAT MEMORIAL HOSPITAL, KOHAT
DOI:
https://doi.org/10.54112/pjicm.v5i02.111Keywords:
Obesity, Pregnancy-Induced Hypertension, Fetomaternal Outcomes, Eclampsia, Preterm Birth, Perinatal MortalityAbstract
Background: Obesity and pregnancy-induced hypertension (PIH) are independently associated with adverse fetomaternal outcomes. When occurring together, they may significantly increase maternal and perinatal morbidity and mortality. Timely identification of complications can guide preventive strategies. Objective: To evaluate the fetomaternal outcomes in obese pregnant women with pregnancy-induced hypertension presenting at Liaqat Memorial Hospital, Kohat, Pakistan. Study Design: Descriptive observational study. Setting: Department of Obstetrics and Gynecology, Liaqat Memorial Hospital, Kohat. Duration of Study: 23-08-2024 to 23-02-2025. Methods: A total of 127 obese pregnant women (BMI ≥30 kg/m²) aged 15–45 years with singleton pregnancies and diagnosed with PIH were enrolled. Fetomaternal outcomes assessed over a 42-day follow-up included eclampsia, HELLP syndrome, placental abruption, fetal growth restriction, preterm birth, fetal hypoxia, perinatal death, and maternal mortality. Data were analyzed using descriptive statistics. Results: The mean age of participants was 28.52 ± 8.89 years. Maternal complications observed were eclampsia in 14.2% of cases, HELLP syndrome in 3.9%, and placental abruption in 7.1%. Fetal complications included fetal growth restriction in 16.5%, preterm birth in 15.7%, fetal hypoxia in 6.3%, and perinatal death in 3.9% of cases. Maternal mortality was recorded in 4.7% of the participants. Conclusion: Among fetal outcomes, fetal growth restriction and preterm birth were the most common complications. In maternal outcomes, eclampsia and placental abruption were the most frequently observed. These findings highlight the need for vigilant monitoring and multidisciplinary management of obese pregnant women with PIH to reduce adverse outcomes.
References
Fisher SC, Van Zutphen AR, Werler MM, Romitti PA, Cunniff C, Browne ML. National Birth Defects Prevention Study. Maternal antihypertensive medication use and selected congenital disabilities in the National Birth Defects Prevention Study. Birth Defects Res. 2018;110(19):1433-42. https://doi.org/10.1002/bdr2.1372
Spiro L, Scemons D. Management of Chronic and Gestational Hypertension of Pregnancy: A Guide for Primary Care Nurse Practitioners. Open Nurs J. 2018;12:180-3. https://doi.org/10.2174/1874434601812010180
Holm L, Stucke-Brander T, Wagner S, Sandager P, Schlütter J, Lindahl C, et al. Automated blood pressure self-measurement station compared to office blood pressure measurement for first-trimester screening of pre-eclampsia. Health Informatics J. 2019;25(4):1815-24. https://doi.org/10.1177/1460458218799505
DeCherney AH, Nathan L, Laufer N, Roman AS, Goodwin M, Nathan L, et al. Current diagnosis and treatment. Obstet Gynecol. 2013. https://www.skinbonescme.com/wp-content/uploads/2023/06/Melissa-Rodriguez-Birthing.Rodriguez-2.pdf
Prakash J, Pandey LK, Singh AK, Kar B. Hypertension in pregnancy: hospital-based study. J Assoc Physic India. 2006;54:273-8. https://europepmc.org/article/med/16944608
Teklu S, Gaym A. Prevalence and clinical correlates of the hypertensive disorders of pregnancy at Tikur Anbessa Hospital, Addis Ababa, Ethiopia. Ethiop Med J. 2006;44(1):17-26. https://europepmc.org/article/med/17447359
Osorio-Yañez, C., et al. "Associations of maternal urinary cadmium with trimester-specific blood pressure in pregnancy: role of dietary intake of micronutrients." Biological trace element research 174.1 (2016): 71-81. https://link.springer.com/article/10.1007/s12011-016-0705-4
Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. GBD 2000 Working Paper, World Health Organization, Geneva. http://www. who. int/evidence/bod.. 2003b.“Global Burden of Obstructed Labor in the Year 2000.” GBD 2000 Working Paper, World Health Organization, Geneva. http://www. who. Int/evidence/bod; 2003.
Parveen N, Haider G, Shaikh IA, Ujjan ID. Presentation of predisposing factors of pregnancy-induced hypertension at Isra University Hospital, Hyderabad. Jlumhs. 2009;8(03):242. https://mail.lumhs.edu.pk/jlumhs/Vol08No03/pdfs/v8n3oa12.pdf
Moodley J. Maternal Deaths Associated with Hypertensive Disorders of Pregnancy: a Population-Based Study. Hypertens Pregnan. 2004;23(3):247-56. https://doi.org/10.1081/PRG-200030301
Lewandowska M, Więckowska B, Sajdak S. Pre-pregnancy obesity, excessive gestational weight gain, and the risk of pregnancy-induced hypertension and gestational diabetes mellitus. J Clin Med. 2020;9(6):1980. https://doi.org/10.3390/jcm9061980
Lewandowska M, Więckowska B, Sajdak S, Lubiński J. Pre-pregnancy obesity vs. other risk factors in probability models of preeclampsia and gestational hypertension. Nutrients. 2020;12(9):2681. https://doi.org/10.3390/nu12092681
Simko M, Totka A, Vondrova D, Samohyl M, Jurkovicova J, Trnka M, et al. Maternal body mass index and gestational weight gain and their association with pregnancy complications and perinatal conditions. Int J Environ Res Public Health. 2019;16(10):1751. https://doi.org/10.3390/ijerph16101751
Akram U, Khattak SN, Kalsoom O, Anwar A, Munir TA. Impact and comparison of pregnancy-induced hypertension and obesity on fetal and maternal outcomes. Pak Armmed Forces Med J. 2019;69(4):1309-14. https://www.nature.com/articles/s41598-017-11432-5
Rahman S, Shabbir S, Moon A, Abbasi TR, Altaf K, Bunyad M. To study the fetomaternal outcomes of pregnancy with obesity: a retrospective case-control study. Liaquat Natl J Prim Care. 2024;6(3):213-9.
Hamid BS, Zuhra H, Jabeen M, Rauf I, Khan F, Saleem M. Adverse Fetomaternal Outcomes in Obese Pregnant Women with Gestational Hypertension. MedERA-Journal of CMH LMC and IOD. 2024;6(2).
Ahmad A, Ahmad S, Afridi H, Afridi IU, Waheed I. Fetomaternal outcome in pregnant females having overweight body mass index during the last trimester. Rawal Med J. 2025;50(2):381-383. https://www.rmj.org.pk/fulltext/27-1747501315.pdf
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 M SALEEM , M JABIN

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.